Urovant Sciences Ltd (UROV)


Stock Price Forecast

March 26, 2021


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Urovant Sciences Ltd chart...

About the Company

We do not have any company description for Urovant Sciences Ltd at the moment.

Exchange

NASDAQ/NGS (GLOBAL SELECT MARKET)

$M

Total Revenue

None

Employees

$503M

Market Capitalization

-3.08

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $UROV News

Urovant Sciences Announces Progression of URO-902 Phase 2a Trial Following Positive Recommendation from the Data & Safety Mon...

1mon ago, source: ADVFN

Urovant Sciences, a subsidiary of Sumitomo Dainippon Pharma Co., Ltd., intends to develop novel treatments for additional urologic diseases. Learn more about us at www.urovant.com. About ...

Roivant Sciences Ltd.

29d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Urovant Sciences to Present at the Jefferies Virtual London Healthcare Conference

1mon ago, source: ADVFN

Urovant Sciences, a subsidiary of Sumitomo Dainippon Pharma Co., Ltd., intends to develop novel treatments for additional urologic diseases. Learn more about us at www.urovant.com. About ...

SMDPY Sumitomo Pharma Co., Ltd.

16d ago, source: Seeking Alpha

and collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company has a strategic alliance with Roivant Sciences Ltd. The company was formerly known as Sumitomo Dainippon ...

Tiziana Life Sciences Ltd Ordinary Shares TLSA

14d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

WAVE Life Sciences Ltd WVE

9d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

StageZero Life Sciences Ltd. (SZLSF)

9d ago, source: Yahoo Finance

TORONTO, ON / ACCESSWIRE / April 5, 2024 /StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi ...

Camlin Fine Sciences Ltd (CAMLINFINE) Share Price

6d ago, source: Business Today

Camlin Fine Sciences Ltd share price was up by 0.42% from the previous closing price of ₹107.90. Who are peers of Camlin Fine Sciences Ltd? The peers of Camlin Fine Sciences Ltd are Pidilite ...

Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in its Expanded Access Program

4d ago, source: Stockhouse

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via ...

JFL Life Sciences Ltd (JFLLIFE) Share Price

29d ago, source: Business Today

JFL Life Sciences Ltd share price was down by -1.63% from the previous closing price of ₹40.00. Who are peers of JFL Life Sciences Ltd? The peers of JFL Life Sciences Ltd are Sun Pharmaceuticals ...

Roivant Sciences Ltd. (ROIV)

2mon ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Roivant Sciences Ltd.

11d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...